STOCKHOLM—The first specialist in pediatric oncology ever to hold office as President of the American Society of Clinical Oncology, Dr Michael Link — Professor of Pediatrics at Stanford University School of Medicine — explains to Peter Goodwin how techniques for treating childhood cancers can be used as models for treating adult malignancy, during the 2011 European Multidisciplinary Cancer Congress held in Stockholm where he chaired a session on “Quality of Delivered Cancer Care”.
You may also like...
Live Report from ASH:
Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML 10 Dec, 2007
Audio Journal of Oncology – June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of George Canellos 3 Jun, 2006 First Line PARP Inhibition For Ovarian Cancer Assessed 2 Nov, 2018 Brachytherapy Improves Survival for Inoperable Early-Stage Endometrial Cancer 28 Apr, 2015
- Previous story Indolent Lymphoma Standard Therapy Needs To Change: Bendamustine-Rituximab: Better Than CHOP-Rituximab
- Next story ASCO 2012 ANNUAL MEETING: Resolving Long Debate, Study Finds Intermittent Hormonal Therapy Less Effective than Continuous Therapy in Certain Men With Advanced Prostate Cancer
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
- MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014